Managing Long-Term Complications After Hematopoietic Stem Cell Transplantation (HSCT),
THURSDAY, SEPT. 11, 2014
Matthew Carabasi, MD, Thomas Jefferson University Hospital
HSCT is a medical procedure that is often performed on patients with certain cancers of the blood or bone marrow, such as multiple myeloma or leukemia. The HSCT procedure involves the transplantation of multipotent hematopoietic stem cells, which are usually derived from bone marrow, peripheral blood, or umbilical cord blood using the patient’s own stem cells or those obtained from a healthy donor. HSCT is one of the revolutionary discoveries of medicine leading to the cure of many of the hematological malignancies and for several nonmalignant conditions. Despite all HSCT’s advances, it still remains a procedure with several potential complications, with infection being one of the major issues. This session will discuss managing long-term complications post HSCT procedure with a focus on complications from bacterial, parasitic, fungal and viral infectious diseases.
- Discuss the HSCT medical procedure.
- Identify the long-term medical complications post HSCT procedure.
- Review the prevention and treatment of HSCT infectious diseases from bacterial, parasitic, fungal and viral complications.
These materials are intended ONLY for pharmacists and pharmacy technicians that attended the presentation, "Managing Long-Term Complications After Hematopoietic Stem Cell Transplantation" held at 4:15 p.m. Thur., Sept. 11, 2014. This session was part of the "23rd Annual National Conference" held in Chicago, Ill. on Sept. 10-12, 2014.
The prerequisite to this process is completing the 23rd Annual National Conference Post-Assessment and Evaluation. If there is a Prerequisite section above and the Status field is blank, click on '23rd Annual National Conference' to open the Assessment and Evaluation.
- 0.75 ACPE - Pharmacists